Clinical trial NCT03859024: Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Official title: Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Pain, Postoperative
Urethral Stricture
Keywords: anterior urethroplasty
pain management
postoperative pain
opioid use
Lead sponsor: University of Alabama at Birmingham
Sponsor class: OTHER
First posted: 2019-03-01
Enrollment: 48
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The investigator's study aims to see if an enhanced recovery regimen of pain medications before and during surgery will decrease the use and risk of opioid pain medications as well as improve pain control in anterior urethroplasty patients. Participants will be randomized to one of two pain regimens (enhanced recovery regimen vs standard regimen).

Detailed description: The purpose of this study is to assess the difference in narcotics usage between two different pain management protocols after urethroplasty. Management at the current time varies between giving intraoperative painkillers along with peripheral nerve blocks in some patients, while others do not receive this protocol. In this study, one group will continue the historical standard of care of the hospital, receiving postoperative nonsteroidal anti-inflammatory drugs (NSAIDs) and narcotics for pain control. The other group will utilize a protocol to lower narcotics usage, including acetaminophen, gabapentin, Celebrex, and local anesthetic (bupivacaine) in an attempt to reduce the usage of narcotics postoperatively. Given the heightened concern over narcotic usage by postoperative patients, including the risk of chronic usage by even young patients, the objective will be to assess if using this protocol as a new standard can limit the need for postoperative narcotics prescriptions.

In related urological procedures, bupivacaine injections given before surgeries have been shown to significantly lower pain scores after surgery for patients undergoing penile prosthesis. The University of Alabama at Birmingham has also been using an Enhanced Recovery After Surgery (ERAS) protocol, a multimodal presurgical care pathway designed to achieve early recovery after surgical procedures, for cystectomy and seen reduced narcotic usage among those patients.

This study would potentially help determine a new pain management protocol for urology patients undergoing anterior urethroplasty that is both more effective and less risky.

Eligibility criteria: Inclusion Criteria:

* Men greater than 18 years of age who are scheduled for anterior urethroplasty surgery

Exclusion Criteria:

* Any patient not classified as a II or III on the American Society of Anesthesiologists (ASA) physical status classification system.
* General anesthesia or neuraxial anesthesia with epidural used as anesthetic techniques
* Allergy/intolerance to local anesthetic or steroids
* Pre-existing neurological and/or anatomical deficit that would preclude regional block
* Coexisting coagulopathy such as hemophilia or von Willebrand Disease
* BMI greater than 40 or less then 20
* History of intravenous drug or opioid abuse
* History of opioid use within a week prior to urethroplasty
* History of any chronic pain syndrome
* Posterior urethroplasty
* Patients with chronic kidney disease
* Patients allergic to NSAIDs
* Patients requiring more than one buccal graft harvest
* Patients with graft urethroplasty with site other than buccal
* Patients with a history of previous urethroplasty

Primary outcomes:
measure: Participant Pain Control: Numerical Rating Scale (NRS)
timeFrame: 3 weeks
measure: Opioid Medication Use
timeFrame: 3 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Birmingham
country: United States
facility: University of Alabama of Birmingham
state: Alabama
Study officials:
affiliation: University of Alabama at Birmingham
name: John P Selph, MD
role: PRINCIPAL_INVESTIGATOR
References: